Analysts Cut Aptiv, Upgrade Henry Schein

Analyst desks were busy Wednesday, with target price moves hitting auto supplier APTV, healthcare distributor HSIC, and insurer HUM.

Aptiv takes the biggest hit. Consensus cut the average target price on Aptiv to $74.11 from $77.67. The auto parts maker has faced persistent pressure from slower EV adoption. Its $12.1 billion market cap puts the downside risk in sharp focus. Short interest sits at 4.8% of free float — modest, but bears have not walked away.

Henry Schein gets a lift. Analysts bumped the dental supply firm's average target to $94.56 from $89.31 — a near-$5 jump. That is a significant move for a mid-cap healthcare name. HSIC carries 6.5% SI % FF. A rising analyst target alongside elevated short interest could squeeze stragglers betting against the stock.

Humana draws a new recommendation. At least one new analyst initiated coverage on HUM, nudging the consensus slightly. The managed-care giant carries a $45 billion market cap. Healthcare names broadly saw active coverage changes today.

Apollo and Gartner also saw target price increases. APO moved to $149.26 and IT to $168.38 — both consensus upgrades in a session dominated by upward revisions outside of auto and fast-food names like MCD.